Piper Sandler raised the firm’s price target on Amgen (AMGN) to $329 from $310 and keeps an Overweight rating on the shares. The firm notes the ...

Piper Sandler analyst David Amsellem reiterated a Buy rating on Amgen (AMGN – Research Report) today and set a price target of $329.00. The ...

Customers who rely on the service contacted Denver7 Investigates after opening the company’s website on Friday to find that ...

Taser maker Axon sees AI-related sales take off and its drone business gain momentum. Axon stock is near a buy point.

Dyne Therapeutics Inc. 4.43% $1.38B ...